📅 Gland Pharma Limited Seasonality
Gland Pharma Limited (GLAND) has ended October higher in 0 of the last 5 years (0%), with an average October move of -6.8%. The strongest October was 2021 (-0.5%) and the weakest was 2022 (-14.7%).
GLAND · data since 2020 (7 yrs)
Prices through 16 Oct 2026
0/5
Octobers closed higher
-6.8%
Avg October move
+5.0%
October so far
July
Best month · avg +8.6%
January
Weakest month · avg -7.3%
7
Years of history
Current month: October 2026
historically up 0% of years (0/5)
avg -6.8%
best 2021 -0.5%
worst 2022 -14.7%
so far +5.0%
Gland Pharma Limited's historically strongest month is July — up in 5 of 6 years (83%) with an average gain of +8.6%. The weakest month has been January, averaging -7.3% with gains in only 2 of 6 years.
📊 Average return by month
Bars above the zero line are months GLAND typically gained; hover for hit rates.
🗓️ Month-by-month returns (2020–2026)
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg | -7.3 | +0.1 | -0.0 | +0.2 | +3.4 | +7.2 | +8.6 | +4.8 | -2.6 | -6.8 | +1.6 | +2.6 |
| Up % | 33% | 50% | 67% | 50% | 67% | 67% | 83% | 50% | 33% | 0% | 40% | 67% |
| 2026 | +7.2 | -1.3 | -6.9 | +3.2 | +28.5 | +10.9 | +0.3 | +15.3 | +0.5 | +5.0 | · | · |
| 2025 | -14.3 | +1.8 | +2.6 | -12.1 | +13.5 | +15.4 | +12.6 | -9.4 | +6.4 | -3.1 | -8.8 | -2.1 |
| 2024 | +1.7 | -9.7 | +4.5 | -7.3 | +7.5 | -0.8 | +17.4 | -14.2 | -2.3 | -8.1 | +5.3 | +2.4 |
| 2023 | -17.5 | +1.3 | -3.8 | +7.1 | -32.0 | +15.0 | +23.1 | +33.2 | -3.8 | -7.7 | +14.8 | +8.4 |
| 2022 | -11.3 | -4.8 | +0.3 | -2.2 | -10.6 | -5.6 | -16.3 | +4.8 | -11.6 | -14.7 | -0.3 | -11.4 |
| 2021 | -9.6 | +13.5 | +3.2 | +12.2 | +13.4 | +8.6 | +14.8 | -0.9 | -4.5 | -0.5 | -3.1 | +7.8 |
| 2020 | · | · | · | · | · | · | · | · | · | · | · | +10.7 |
🏆 Top 25 seasonal picks — October 2026
| # | Stock | Record | Win % | Avg return | So far |
|---|---|---|---|---|---|
| 1 | MUTHOOTFIN Muthoot Finance Limited | 13/15 yrs up | 87% | +4.4% | -5.1% |
| 2 | POKARNA Pokarna Limited | 9/10 yrs up | 90% | +9.7% | +1.2% |
| 3 | STYRENIX Styrenix Performance Materials Limited | 18/22 yrs up | 82% | +3.7% | +2.3% |
| 4 | TBZ Tribhovandas Bhimji Zaveri Limited | 12/14 yrs up | 86% | +12.3% | +19.5% |
| 5 | RAMCOCEM The Ramco Cements Limited | 17/22 yrs up | 77% | +0.6% | -4.8% |
| 6 | OBEROIRLTY Oberoi Realty Limited | 12/15 yrs up | 80% | +6.1% | -3.5% |
| 7 | PDSL PDS Limited | 9/11 yrs up | 82% | +9.4% | -2.8% |
| 8 | MCX Multi Comm. Exc. | 11/14 yrs up | 79% | +8.9% | -4.2% |
| 9 | INDOTECH Indo Tech Transformers Limited | 15/20 yrs up | 75% | +6.7% | -3.8% |
| 10 | SUZLON Suzlon Energy Limited | 15/20 yrs up | 75% | +4.8% | +6.4% |
| 11 | RSYSTEMS R Systems International Limited | 15/20 yrs up | 75% | +4.2% | -6.6% |
| 12 | IFBAGRO IFB Agro Industries Limited | 16/22 yrs up | 73% | +11.7% | -3.1% |
| 13 | GMDCLTD Gujarat Mineral Development Corporation Limited | 16/22 yrs up | 73% | +8.5% | -7.2% |
| 14 | USHAMART Usha Martin Limited | 16/22 yrs up | 73% | +6.0% | -1.5% |
| 15 | GSFC Gujarat State Fertilizers & Chemicals Limited | 16/22 yrs up | 73% | +4.6% | -1.3% |
| 16 | ICICIBANK ICICI Bank Limited | 16/22 yrs up | 73% | +4.5% | +5.7% |
| 17 | SHRIRAMFIN Shriram Finance Limited | 16/22 yrs up | 73% | +2.8% | -4.3% |
| 18 | KABRAEXTRU Kabra Extrusion Technik Limited | 16/22 yrs up | 73% | +2.2% | +0.4% |
| 19 | HIRECT Hind Rectifiers Limited | 14/19 yrs up | 74% | +4.7% | -2.7% |
| 20 | TI Tilaknagar Industries Limited | 12/16 yrs up | 75% | +9.5% | +2.0% |
| 21 | KECL Kirloskar Electric Company Limited | 12/16 yrs up | 75% | +8.0% | -1.9% |
| 22 | IMFA Indian Metals & Ferro Alloys Limited | 12/16 yrs up | 75% | +8.0% | -0.9% |
| 23 | DBREALTY Valor Estate Limited | 12/16 yrs up | 75% | +7.4% | -9.7% |
| 24 | ATULAUTO Atul Auto Limited | 10/13 yrs up | 77% | +8.3% | -5.6% |
| 25 | MINDTECK Mindteck (India) Limited | 8/10 yrs up | 80% | +5.1% | -2.8% |
“So far” = return in the current (incomplete) period. Full methodology and the
past-performance record of these lists: Seasonality hub →
Current quarter: Q4 2026
historically up 40% of years (2/5)
avg -4.1%
so far +5.0%
By quarter, Q3 (Jul–Sep) has been the strongest for GLAND: up in 4 of 6 years, averaging +11.2%. Q1 (Jan–Mar) has been the softest (-7.5% on average). The current quarter (Q4) has historically closed higher 40% of the time.
📊 Average return by quarter
Calendar quarters, close-to-close. Hover for hit rates.
🗓️ Quarter-by-quarter returns
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| Avg | -7.5 | +10.9 | +11.2 | -4.1 |
| Up % | 17% | 50% | 67% | 40% |
| 2026 | -1.5 | +47.1 | +16.2 | +5.0 |
| 2025 | -10.5 | +15.1 | +8.6 | -13.5 |
| 2024 | -4.1 | -1.1 | -1.6 | -0.9 |
| 2023 | -19.6 | -16.2 | +57.7 | +14.9 |
| 2022 | -15.3 | -17.4 | -22.5 | -24.7 |
| 2021 | +5.9 | +38.2 | +8.6 | +3.9 |
🏆 Top 25 seasonal picks — Q4 2026
| # | Stock | Record | Win % | Avg return | So far |
|---|---|---|---|---|---|
| 1 | RHIM RHI MAGNESITA INDIA LIMITED | 13/14 yrs up | 93% | +14.0% | -3.8% |
| 2 | APOLLOHOSP Apollo Hospitals Enterprise Limited | 19/22 yrs up | 86% | +6.2% | -3.4% |
| 3 | RSYSTEMS R Systems International Limited | 17/20 yrs up | 85% | +24.7% | -6.6% |
| 4 | STAR Strides Pharma Science Limited | 18/22 yrs up | 82% | +6.3% | -6.7% |
| 5 | DRREDDY Dr. Reddy's Laboratories Limited | 18/22 yrs up | 82% | +4.5% | +0.0% |
| 6 | PROZONER Prozone Realty Limited | 12/14 yrs up | 86% | +19.8% | -3.9% |
| 7 | POLYMED Poly Medicure Limited | 12/14 yrs up | 86% | +9.2% | -4.8% |
| 8 | INDOTECH Indo Tech Transformers Limited | 16/20 yrs up | 80% | +23.2% | -3.8% |
| 9 | TI Tilaknagar Industries Limited | 13/16 yrs up | 81% | +22.7% | +2.0% |
| 10 | FIEMIND Fiem Industries Limited | 15/19 yrs up | 79% | +14.2% | +2.2% |
| 11 | BSOFT BIRLASOFT LIMITED | 17/22 yrs up | 77% | +21.8% | +17.1% |
| 12 | SONATSOFTW Sonata Software Limited | 17/22 yrs up | 77% | +20.2% | -4.0% |
| 13 | FACT Fertilizers and Chemicals Travancore Limited | 17/22 yrs up | 77% | +20.1% | -3.3% |
| 14 | TVSHLTD TVS Holdings Limited | 17/22 yrs up | 77% | +15.4% | -5.0% |
| 15 | APARINDS Apar Industries Limited | 17/22 yrs up | 77% | +15.1% | -7.8% |
| 16 | STYRENIX Styrenix Performance Materials Limited | 17/22 yrs up | 77% | +11.0% | +2.3% |
| 17 | EPL EPL Limited | 17/22 yrs up | 77% | +10.4% | -2.1% |
| 18 | TORNTPHARM Torrent Pharmaceuticals Limited | 17/22 yrs up | 77% | +8.5% | -5.0% |
| 19 | WIPRO Wipro Limited | 17/22 yrs up | 77% | +8.4% | +16.3% |
| 20 | HINDALCO Hindalco Industries Limited | 17/22 yrs up | 77% | +7.6% | -3.6% |
| 21 | VTL Vardhman Textiles Limited | 17/22 yrs up | 77% | +7.4% | -0.5% |
| 22 | HDFCBANK HDFC Bank Limited | 17/22 yrs up | 77% | +6.2% | +2.8% |
| 23 | COROMANDEL Coromandel International Limited | 17/22 yrs up | 77% | +5.9% | +0.0% |
| 24 | ASIANPAINT Asian Paints Limited | 17/22 yrs up | 77% | +4.3% | -2.9% |
| 25 | JPOLYINVST Jindal Poly Investment and Finance Company Limited | 10/12 yrs up | 83% | +34.9% | +2.1% |
“So far” = return in the current (incomplete) period. Full methodology and the
past-performance record of these lists: Seasonality hub →
❓ GLAND seasonality — FAQ
How often does Gland Pharma Limited rise in October?
Historically GLAND has closed October with a gain in 0 out of 5 years — a 0% hit rate — averaging -6.8% for the month (data since 2020).
Which is the best month to buy Gland Pharma Limited historically?
Based on 6 years of data, July has been GLAND's strongest month: positive in 83% of years with an average return of +8.6%. Past seasonality does not guarantee future results.
Which is the weakest month for Gland Pharma Limited?
January has historically been the weakest month for GLAND, with an average move of -7.3% and gains in just 2 of 6 years.
Which quarter is historically strongest for Gland Pharma Limited?
Q3 (Jul–Sep) — positive in 4 of 6 years with an average return of +11.2%.
Does seasonality guarantee future returns?
No. Seasonality is a historical tendency, not a prediction. It reflects how a stock happened to trade in past calendar periods and can break at any time. Use it as one research input alongside fundamentals and technicals, and consult a SEBI-registered adviser before investing.
Methodology: returns are close-to-close over calendar months and quarters, computed from adjusted daily prices since 2020. A period's return is only counted when the immediately preceding period also traded. Statistics cover completed periods; the current period is shown separately as “so far”. Seasonality is a historical tendency, not a prediction or investment advice. Consult a SEBI-registered adviser before investing.
